Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-24

Clinical Trial Update: P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne [Phase 3]

View source ↗

Summary

Phase 3 trial assessing once-daily SB204 gel vs vehicle gel for acne vulgaris has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SB204

Snippet

Sponsor: Novan, Inc. | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2023-07-24